JUL 19, 2016 9:25 AM PDT

New cures for the common cold?

WRITTEN BY: Kerry Evans
The common cold virus grows best at cooler temperatures (like in your nose), just a few degrees below core body temperature. Why? Because various components of the immune system work better at warm temperatures. Recently, Yale researchers identified two new temperature-dependent host defense strategies that combat the common cold.

The same group already showed that interferon is secreted at 37oC (98.6oF, core body temperature) in response to the cold virus - rhinovirus (RV). However, when they inhibited the interferon response, viral replication still depended partially on temperature, suggesting that additional temperature-dependent antiviral activities were at play.
 
Researchers identified new host defenses against the common cold.
Ultimately, they showed that, at 37oC compared to 33oC, RV-infected cells underwent apoptosis earlier at 37oC than at the cooler temperature of 33oC; virus replication also decreased at 37oC compared to 33oC. In addition, they showed that the RNA-degrading enzyme RNAseL effectively decreased RV replication at 37oC versus 33oC.

To show that apoptosis helped curb viral replication at 37oC, they overexpressed the anti-apoptotic protein Bcl-2. RV replication increased in cells when Bcl-2 was overexpressed (to inhibit apoptosis).

Since dsRNAs accumulate during RV infection, they reasoned that the RNA-degrading enzyme RNAseL may be expressed at a higher level at 37oC than 33oC. This was indeed the case. The level of RNAseL mRNA was 2.2-fold higher at 37oC than 33oC. They used siRNA to knockdown RNAseL production in RV-infected cells; RNAseL knockdown increased RV replication at 37oC compared to when RNaseL was not overexpressed at this temperature..

What’s more, the group found that apoptosis and RNaseL are redundant mechanisms that cells use to control virus replication. To show this, they compared the effects of inhibiting apoptosis and RNAseL simultaneously or separately. In infected control cells, there was a 42-fold difference in peak viral titer at 33oC versus 37oC (indicating enhanced viral replication at 33oC). The difference was 61-fold or 13-fold if RNAseL or apoptosis were inhibited, respectively. However, if both RNAaseL and apoptosis were inhibited simultaneously, there was only a 5-fold difference in peak viral titer.

Overall, these findings reveal new ways to target the common cold, and this is especially important for people who have a weakened immune system or asthma, since the virus can exacerbate symptoms.

Sources: PNAS, Yale, Wikipedia
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
NOV 27, 2019
Immunology
NOV 27, 2019
Playing "Tag" with the Immune System
Human cells employ an intricate tagging system to manage protein activity in the body. By “tagging” a protein with a certain modification, cell...
DEC 05, 2019
Drug Discovery & Development
DEC 05, 2019
New Injection that Treats Peanut Allergy
Peanut allergies affect between 1 and 3% of the US population. Associated with a heightened risk of severe anaphylactic reactions, oral immunotherapy is th...
JAN 11, 2020
Microbiology
JAN 11, 2020
Twins Still Have Microbial Strains in Common After Living Apart for Years
Twins can offer researchers an opportunity to study health and biology in people with the same genes, raised in the same environment....
JAN 15, 2020
Microbiology
JAN 15, 2020
Scientists Engineer a New Kind of Life Form
Usig cells harvested from frogs, researchers created tiny robots....
JAN 27, 2020
Microbiology
JAN 27, 2020
Microbes in Household Dust May Be Spreading Antibiotic Resistance
Bacteria live in household dust, and sometimes a few of those microbes are pathogenic or carry genes that confer resistance to antibiotics....
FEB 14, 2020
Microbiology
FEB 14, 2020
CDC Director Expects Coronavirus to Find a "Foothold"
The novel coronavirus that emerged in Wuhan, Hubei Province, China has now infected over 64,000 people....
Loading Comments...